These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 37605396)
1. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients. Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396 [TBL] [Abstract][Full Text] [Related]
2. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Harr T; French LE Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721 [TBL] [Abstract][Full Text] [Related]
3. Stevens-Johnson syndrome and toxic epidermal necrolysis. Harr T; French LE Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860 [TBL] [Abstract][Full Text] [Related]
4. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475 [TBL] [Abstract][Full Text] [Related]
5. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Chang CC; Too CL; Murad S; Hussein SH Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392 [TBL] [Abstract][Full Text] [Related]
6. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M; Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896 [TBL] [Abstract][Full Text] [Related]
7. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype. Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440 [TBL] [Abstract][Full Text] [Related]
8. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Hung SI; Chung WH; Liu ZS; Chen CH; Hsih MS; Hui RC; Chu CY; Chen YT Pharmacogenomics; 2010 Mar; 11(3):349-56. PubMed ID: 20235791 [TBL] [Abstract][Full Text] [Related]
9. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis. Chung WH; Hung SI Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. Hasegawa A; Abe R F1000Res; 2020; 9():. PubMed ID: 32595945 [TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988 [TBL] [Abstract][Full Text] [Related]
13. Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study. Dastgheib L; Rostami F; Gharesi-Fard B; Asadi-Pooya AA; Namjoo S; Tahmasebi F; Hadibarhaghtalab M Iran J Med Sci; 2023 Jan; 48(1):70-76. PubMed ID: 36688194 [TBL] [Abstract][Full Text] [Related]
14. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. Schwartz RA; McDonough PH; Lee BW J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879 [TBL] [Abstract][Full Text] [Related]
15. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis. Rashid M; Rajan AK; Chhabra M; Kashyap A; Chandran VP; Venkataraman R; Nair S; Thunga G Seizure; 2022 Nov; 102():36-50. PubMed ID: 36183454 [TBL] [Abstract][Full Text] [Related]
16. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Cheung YK; Cheng SH; Chan EJ; Lo SV; Ng MH; Kwan P Epilepsia; 2013 Jul; 54(7):1307-14. PubMed ID: 23692434 [TBL] [Abstract][Full Text] [Related]
17. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R; Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717 [TBL] [Abstract][Full Text] [Related]
18. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH; Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699 [TBL] [Abstract][Full Text] [Related]
19. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders. Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH; J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642 [TBL] [Abstract][Full Text] [Related]
20. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L; Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]